<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>15(46)</volume><submitter>Elgohary MK</submitter><pubmed_abstract>This study aimed to discover novel multifunctional anticonvulsant agents through the evaluation of a series of test compounds 5d-f, 7b, and 10c-f, which were previously identified based on their potent anti-inflammatory activity in both &lt;i>in vitro&lt;/i> and &lt;i>in vivo&lt;/i> models in acute and chronic seizure models. Initial screening in the pentylenetetrazol (PTZ)-induced seizure model identified compounds 7b, 5f, 5e, and 10c as the most effective, with compound 7b demonstrating complete seizure protection (100%) and zero mortality, outperforming the reference drug valproic acid (VI). These four candidates were further assessed in the pilocarpine-induced temporal lobe epilepsy model. Compound 7b again showed superior efficacy, significantly delaying seizure onset by 188.6%, reducing seizure </pubmed_abstract><journal>RSC advances</journal><pagination>39161-39179</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12531995</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Discovery and characterization of phenoxyacetic acid derivatives as potential antiepileptic agents.</pubmed_title><pmcid>PMC12531995</pmcid><pubmed_authors>Abdel-Aziz HA</pubmed_authors><pubmed_authors>Naglah AM</pubmed_authors><pubmed_authors>Fares M</pubmed_authors><pubmed_authors>Eldehna WM</pubmed_authors><pubmed_authors>Almehizia AA</pubmed_authors><pubmed_authors>Alqarni MH</pubmed_authors><pubmed_authors>Elgohary MK</pubmed_authors><pubmed_authors>Alkabbani MA</pubmed_authors><pubmed_authors>Elkotamy MS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Discovery and characterization of phenoxyacetic acid derivatives as potential antiepileptic agents.</name><description>This study aimed to discover novel multifunctional anticonvulsant agents through the evaluation of a series of test compounds 5d-f, 7b, and 10c-f, which were previously identified based on their potent anti-inflammatory activity in both &lt;i>in vitro&lt;/i> and &lt;i>in vivo&lt;/i> models in acute and chronic seizure models. Initial screening in the pentylenetetrazol (PTZ)-induced seizure model identified compounds 7b, 5f, 5e, and 10c as the most effective, with compound 7b demonstrating complete seizure protection (100%) and zero mortality, outperforming the reference drug valproic acid (VI). These four candidates were further assessed in the pilocarpine-induced temporal lobe epilepsy model. Compound 7b again showed superior efficacy, significantly delaying seizure onset by 188.6%, reducing seizure </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Oct</publication><modification>2026-06-04T14:12:19.943Z</modification><creation>2026-05-10T03:11:14.316Z</creation></dates><accession>S-EPMC12531995</accession><cross_references><pubmed>41113602</pubmed><doi>10.1039/d5ra05596b</doi></cross_references></HashMap>